AB
RLYB icon

Amalgamated Bank’s Rallybio RLYB Stock Holding History

Amalgamated Bank’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-70
Closed -$1K – 3095
2024
Q1 		$1K Sell
70
-204
-74% -$2.84K ﹤0.01% 2927
2023
Q4 		$5K Sell
274
-21
-7% -$513 ﹤0.01% 2943
2023
Q3 		$8K Hold
295
– – ﹤0.01% 2934
2023
Q2 		$13K Hold
295
– – ﹤0.01% 2915
2023
Q1 		$13K Sell
295
-11
-4% -$568 ﹤0.01% 2768
2022
Q4 		$16K Hold
306
– – ﹤0.01% 2802
2022
Q3 		$35K Buy
306
+4
+1% +$356 ﹤0.01% 2613
2022
Q2 		$18K Buy
302
+169
+127% +$12.7K ﹤0.01% 2885
2022
Q1 		$7K Buy
+133
New +$11K ﹤0.01% 3004

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Bank's RLYB Position: Q2 2024 in Review

Amalgamated Bank sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 70 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in RLYB in Q1 2022 and held it in 9 quarters. The position peaked at $35K in Q3 2022. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Amalgamated Bank reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 70 Rallybio shares in Q2 2024, an estimated $1K.
  • Amalgamated Bank first reported a position in Rallybio in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Rallybio position peaked at $35K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.